GSK Recalling Lamictal Starter Kits Due To Incorrect Doses
Executive Summary
GlaxoSmithKline is recalling all lots of its Lamictal (lamotrigine) starter kits after some packs were found to contain incorrect dosage strengths of the anti-epileptic
You may also be interested in...
Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet threatens $1 bil. in annual revenues for the company
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials